Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

PM

Park Medi World IPO

Listed MAINBOARD BSE, NSE · Hospital

Price Band

₹154.0–162.0

Issue Size

₹920.0 Cr

Lot Size

92 shares

Min Investment

₹14,904

GMP

Grey Market Premium — the unofficial premium buyers are currently willing to pay over the issue price once this IPO lists. It's an informal market estimate, not guaranteed, and can move daily right up to listing day. Learn more: GMP vs Kostak vs Sauda →

—

Issue Price

₹162.0

Park Medi World IPO AI Summary

  • Park Medi World IPO is listed on BSE, NSE in the Hospital sector.
  • Price band: ₹154.0–₹162.0 per share, lot size 92 shares (min. investment ₹14,904).
  • Subscription window: 10 Dec–12 Dec 2025, listing on 17 Dec 2025.

Park Medi World Limited, a prominent private hospital chain in North India, is set to launch its IPO with an issue price of ₹162. The company aims to utilize the funds for debt repayment, capital expenditures, and acquisitions. Investors should consider the potential for both gains and risks associated with IPO investments.

TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.

Park Medi World IPO — Third-Party Research Views

Reviews below reflect analyst calls made before this IPO closed on 12 Dec 2025 — not a current signal.

2 of 2 reviewers say Neutral

Neutral 25 Jul
Neutral 25 Jul

Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.

Important Dates

IPO Open Date
Wed, 10 Dec 2025
IPO Close Date
Fri, 12 Dec 2025
Allotment Date
Mon, 15 Dec 2025
Refund Initiation
Tue, 16 Dec 2025
Credit of Shares
Tue, 16 Dec 2025
Listing Date
Wed, 17 Dec 2025
Listing Price
₹162.0 +0.0%

Subscription Status

Subscription data unavailable

Park Medi World IPO Grey Market Premium (GMP) Today

GMP not available yet

Grey Market Premium is updated daily. Check back closer to the listing date.

About the Company

Incorporated in 2011, Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025. The company operates 14 multi-super speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan. Park Hospital offers more than 30 super speciality and speciality services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology. As of Sep 30, 2025, the hospitals are equipped with 870 bedded intensive care unit (ICU) beds, 67 operating theatres (OTs), and an oxygen generation plant at each location to support critical care. It has hospitals across several states including Haryana (Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad), Delhi, Punjab (Patiala, Mohali), and Rajasthan (Jaipur, Behror). As of September 30, 2025, Park Medi World Limited had a workforce of 1,014 doctorsa and 2,142 nurses . Competitive strengths: Second largest chain of private hospitals in North India and largest private hospital chain in Haryana Delivering high-quality and affordable healthcare with a diverse specialty mix Track record of successfully acquiring and integrating hospitals Strong operational and financial performance with diversified payor mix Doctor led professional management team with industry experience

Company Financials (₹ Cr)

As of 2025-09-30

Period Ended 30 Sep 2025 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 2,320.93 2,133.70 1,912.10 1,592.82
Total Income 823.39 1,425.97 1,263.08 1,272.18
Profit After Tax 139.14 213.22 152.01 228.19
EBITDA 217.14 372.17 310.30 390.34
NET Worth 1,153.05 1,021.86 815.98 667.55
Reserves and Surplus 1,187.77 1,049.40 858.63 653.09
Total Borrowing 733.91 682.07 686.71 575.68

Key Ratios

EPS

₹5.55

NAV

₹26.58

ROE

20.68%

ROCE

17.47%

RoNW

20.08%

P/B Value

6.09

P/E Ratio

29.21

Market Cap

₹6997.28 Cr

PAT Margin

15.30%

Debt/Equity

0.61

Peer Comparison

Company NAV RoNW P/E (x) EPS Basic EPS Diluted
Yatharth Hospital & Trauma Care Services Ltd. 166.62 8.15% 52.85 14.72 14.72
Jupiter Lifeline Hospitals Ltd 206.85 14.27% 48.59 29.47 29.47
Global Health Ltd. 125.64 14.27% 66.41 17.92 17.92
Krishna Institute of Medical Sciences Ltd. 53.43 17.89% 69.53 9.61 9.61
Max Healthcare Institute Ltd. 96.5 11.47% 101.54 11.07 11.07
Narayana Hrudalaya Ltd. 177.37 21.8% 50.1 38.9 38.9
Fortis Healthcare Ltd. 118.06 8.69% 90.42 10.26 10.26
Apollo Hospitals Enterprise Ltd. 570.37 17.63% 73.43 100.56 100.56
Park Medi World Ltd. This IPO 26.58 20.08% — 5.55 5.55

Promoters

Ajit Gupta and Ankit Gupta

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries. 380.00 2 Funding capital expenditure for development of new hospital and expansion of existing hospital by certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively. 60.50 3 Funding capital expenditure for purchase of medical equipment by the Company and certain Subsidiaries, Blue Heavens and Ratangiri. 27.46 4 Unidentified inorganic acquisitions and general corporate purposes. 245.32 5 Issue Expenses 67.77 Total 781.05

IPO Evaluation

Generated 23 Sep 2026

Revenue Trend

Total income was ₹1,272.18 Cr in the year ending March 31, 2023, rising to ₹1,263.08 Cr by March 31, 2024. This increased further to ₹1,425.97 Cr in the year ending March 31, 2025, but fell to ₹823.39 Cr by September 30, 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.

Profit Trend

Profit after tax was ₹228.19 Cr in the year ending March 31, 2023, decreasing to ₹152.01 Cr by March 31, 2024. This rose to ₹213.22 Cr in the year ending March 31, 2025, but fell to ₹139.14 Cr by September 30, 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.

Valuation

Park Medi World Limited has an implied P/E ratio of 29.21 at the issue price, compared to peers trading at a P/E range of 48.59 to 101.54.

Grey Market Premium, Explained

The grey market refers to the unofficial market where shares of an IPO are traded before they are listed on the stock exchange. The Grey Market Premium (GMP) indicates the expected listing price of the IPO based on current trading in the grey market. A higher GMP suggests positive sentiment among investors regarding the IPO's performance upon listing.

Who This IPO Suits

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk appetite. Consideration of the company's fundamentals and market position is also important.

Who May Want to Wait

Investors who prefer stable, established companies may want to avoid IPOs like this, which can be subject to market fluctuations and uncertainties inherent in the healthcare sector.

IPO Timeline, Explained

The IPO opens for subscription on December 10, 2025, and closes on December 12, 2025. Allotment of shares will be done by December 15, 2025, with shares expected to list on the stock exchange on December 17, 2025.

Listing Gains — The Risk

Listing gains refer to the profit made when shares are sold on the listing day at a price higher than the issue price. However, there is no guarantee of listing gains, as market conditions can fluctuate significantly. Investors should be prepared for the possibility of losses as well.

This evaluation is generated from Park Medi World's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.

Frequently Asked Questions

What is the price band of Park Medi World IPO?

The price band of Park Medi World IPO is ₹154.0–₹162.0 per share.

When does Park Medi World IPO open and close?

Park Medi World IPO opens on 10 December 2025 and closes on 12 December 2025.

When does Park Medi World IPO list on the stock exchange?

Park Medi World IPO listed on 17 December 2025 at ₹162.0.

What is the lot size for Park Medi World IPO?

The lot size for Park Medi World IPO is 92 shares, requiring a minimum investment of ₹14,904.

What is the lot size for the Park Medi World IPO?

The lot size for the Park Medi World IPO is 92 shares.

What is the minimum investment required?

The minimum investment required is ₹14,904.

What is the price band for the IPO?

The price band for the IPO is between ₹154.0 and ₹162.0.

When does the IPO open and close?

The IPO opens on December 10, 2025, and closes on December 12, 2025.

What does GMP mean?

GMP stands for Grey Market Premium, which indicates the expected listing price of the IPO based on unofficial trading.

Issue Details

Issue Type MAINBOARD Book Built
Issue Size ₹920.0 Cr
Price Band ₹154.0 – ₹162.0
Issue Price ₹162.0
Lot Size 92 shares
Min Investment ₹14,904
Exchange BSE, NSE
Sector Hospital
Open Date 10 Dec 2025
Close Date 12 Dec 2025
Allotment 15 Dec 2025
Listing Date 17 Dec 2025

Investor Allocation

QIB (Institutional) 50%
NII / HNI 15%
Retail (RII) 35%

Registrar

Kfin Technologies Ltd.

Lead Managers / Book Running

Dam Capital Advisors Ltd.
Intensive Fiscal Services Pvt.Ltd.
CLSA India Pvt.Ltd.
Nuvama Wealth Management Ltd.

IPO Timeline

Open

10 Dec 2025

Close

12 Dec 2025

Allotment

15 Dec 2025

Listing

17 Dec 2025

Community Sentiment

What are other investors planning for Park Medi World?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.